ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,822,000 | +83.0% | 82,500 | -3.7% | 0.48% | +69.0% |
| Q1 2019 | $2,088,000 | 0.0% | 85,645 | 0.0% | 0.28% | 0.0% |
| Q4 2018 | $2,088,000 | 0.0% | 85,645 | 0.0% | 0.28% | 0.0% |
| Q3 2018 | $2,088,000 | -12.0% | 85,645 | -39.5% | 0.28% | -10.5% |
| Q2 2018 | $2,374,000 | +2.8% | 141,470 | 0.0% | 0.31% | +4.0% |
| Q1 2018 | $2,309,000 | +27.5% | 141,470 | 0.0% | 0.30% | +27.4% |
| Q4 2017 | $1,811,000 | +4.1% | 141,470 | 0.0% | 0.24% | -1.7% |
| Q3 2017 | $1,740,000 | +47.0% | 141,470 | 0.0% | 0.24% | +35.4% |
| Q2 2017 | $1,184,000 | -6.4% | 141,470 | 0.0% | 0.18% | -3.3% |
| Q1 2017 | $1,265,000 | +1.7% | 141,470 | 0.0% | 0.18% | -2.1% |
| Q4 2016 | $1,244,000 | +8.4% | 141,470 | -16.8% | 0.19% | +13.3% |
| Q3 2016 | $1,148,000 | +89.8% | 170,000 | 0.0% | 0.17% | +78.5% |
| Q2 2016 | $605,000 | +20.5% | 170,000 | 0.0% | 0.09% | +9.4% |
| Q1 2016 | $502,000 | -30.0% | 170,000 | 0.0% | 0.08% | -33.1% |
| Q4 2015 | $717,000 | -7.5% | 170,000 | 0.0% | 0.13% | -5.2% |
| Q3 2015 | $775,000 | -36.8% | 170,000 | 0.0% | 0.13% | -23.9% |
| Q2 2015 | $1,226,000 | -2.2% | 170,000 | 0.0% | 0.18% | +6.0% |
| Q1 2015 | $1,253,000 | +55.8% | 170,000 | 0.0% | 0.17% | +56.6% |
| Q4 2014 | $804,000 | +32.5% | 170,000 | 0.0% | 0.11% | +27.7% |
| Q3 2014 | $607,000 | -21.7% | 170,000 | 0.0% | 0.08% | -20.2% |
| Q2 2014 | $775,000 | -3.0% | 170,000 | 0.0% | 0.10% | -11.9% |
| Q1 2014 | $799,000 | -11.4% | 170,000 | -5.6% | 0.12% | -19.7% |
| Q4 2013 | $902,000 | – | 180,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |